Minnesota boasts history in drug operations jobs

Although admittedly a minor player, Minnesota was adding pharma manufacturing jobs as late as 2008--before the add rate dipped in 2009. And in the five years preceding 2008, the North Star State saw a 76-percent growth in drug ops positions.

That's according to a statewide assessment conducted for the BioBusiness Alliance of Minnesota by Willoughby International. The growth rate tops that of 11 competing states, including  New Jersey, New York, Massachusetts and California.

Minnesota's biggest life sciences player is the medical device industry. President Kelvin Willoughby suggests that the combination of pharmaceuticals with medical devices could be driving the growth.

- see the article
- here's the report (PDF)

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.